Home > Investor

Investor

Share Trends
Stock Performance
Warsaw Stock Exchange
Bulgarian Stock Exchange
Corporate News
22 February 2018
Sopharma’s smoking cessation drug with positive preliminary clinical data in the US
Financial News
23 February 2018
Decisions taken at the Extraordinary General Meeting of Shareholders of Sopharma AD, held on 23.02.2018
8 February 2018
Notification for acquisition of own shares
5 February 2018
Sales revenues for January 2018
Financial Highlights 31 December 2016
877,085
BGN '000 Revenue
73,656
BGN '000 EBITDA
44,951
BGN '000 Revenue from operating profit
54,902
BGN '000 Net profit for the year
0.39
BGN Earnings per share

Next events
5 March 2018
Financial Revenues for January-February 2018
20 March 2018
Meeting of the Board of Directors for adoption of the annual financial statement.

Equity story

80+ year track record in the pharma industry

  • Leadership
  • Growth
  • Portfolio
  • Profitability
  • Business Model
  • M&A